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A B S T R A C T
Background: Exposure to triclosan, an antimicrobial chemical, is ubiquitous among pregnant women and may
reduce thyroid hormone levels that are important for fetal neurodevelopment. Few studies have examined the
association between prenatal triclosan exposure and children's neurobehavior.
Objective: We investigated the relationship of prenatal urinary triclosan concentrations with children's behavior
and cognitive abilities at age three years in a prospective pregnancy and birth cohort in Canada.
Methods: We measured triclosan in urine samples collected at ~12weeks of gestation in 794 Canadian women
enrolled in a prospective pregnancy and birth cohort study (MIREC) from 2008 to 2011. Around age 3 years, we
assessed children's cognitive abilities using the Wechsler Primary and Preschool Scale of Intelligence-III (WPPSI-
III), and two scales of the Behavior Rating Inventory of Executive Function-Preschool (BRIEF-P). Parents re-
ported children's problem and reciprocal social behaviors using the Behavior Assessment System for Children-2
(BASC-2) and Social Responsiveness Scale-2 (SRS-2), respectively.
Results: After adjusting for confounders using multivariable linear regression, triclosan was not associated with
most of the 30 examined neurobehavioral scales. Each 10-fold increase in triclosan was associated with better
WPPSI-III picture completion scores (β: 0.2; 95% CI: 0,0.5) and BASC-2 externalizing (β:−0.5; 95% CI: −1.1, 0)
and hyperactivity (β: −0.6; 95% CI: −1.2, −0.1) scores, suggesting less externalizing and hyperactive beha-
viors. Child sex did not modify these associations.
Conclusions: In this cohort, urinary triclosan concentrations measured once in early pregnancy were not asso-
ciated with most assessed aspects of neurobehavior and weakly associated with a few others, but not in the
hypothesized direction.
1. Introduction
Triclosan is an antimicrobial chemical used in some personal care
and consumer products. The U.S. Food and Drug Administration banned
triclosan in over-the-counter consumer wash products in 2016 in part
because of concerns about its developmental toxicity (Safety and
Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug
Products for Over-the-Counter Human Use, 2016); however, other
sources of triclosan exposure remain in commerce, including some
toothpastes, body lotions, cosmetics, toys, textiles, and kitchenware
(Dann and Hontela, 2011; Rodricks et al., 2010). Triclosan is detected
in the urine of> 80% of pregnant women in North America, indicating
nearly ubiquitous exposure among this sensitive population (Woodruff
et al., 2011; Etzel et al., 2017; Arbuckle et al., 2015a).
Prenatal triclosan exposure may adversely impact fetal neurodeve-
lopment by affecting the hypothalamic-pituitary-thyroid axis during
gestation (Brucker-Davis, 1998). Thyroid hormones play a critical role
in fetal growth and neurodevelopment (de Escobar et al., 2004;
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Ghassabian et al., 2011; Gilbert et al., 2012; Zoeller and Rovet, 2004;
Henrichs et al., 2010; Korevaar et al., 2016; Ghassabian et al., 2012;
Andersen et al., 2014; Modesto et al., 2015; Brown et al., 2015; Lyall
et al., 2016; Yau et al., 2015) and reduced levels of thyroid hormones
during gestation can affect fetal neurodevelopment, which in turn may
increase the risk of cognitive and motor deficits, as well as behavioral
disorders. Rodent studies show that triclosan exposure can reduce
thyroxine concentrations in pregnant, fetal, and juvenile rats (Johnson
et al., 2016; Paul et al., 2012; Paul et al., 2010). Two epidemiological
studies found an inverse association of prenatal urinary triclosan con-
centrations with maternal and cord blood thyroxine and triiodothyr-
onine levels (Wang et al., 2017; Braun et al., 2017a). In addition, in
vitro studies show that triclosan exposure induces apoptosis in neo-
cortical neurons (Szychowski et al., 2015; Szychowski et al., 2016).
We are not aware of any animal studies examining the neurotoxicity
of triclosan exposure; one epidemiological study found no association
between prenatal triclosan exposure and children's visual-spatial abil-
ities (Braun et al., 2017b). Given the potential for triclosan to disrupt
thyroid hormone homeostasis, we investigated the relationship of pre-
natal urinary triclosan concentrations with children's behavior and
cognitive abilities at age three years in a prospective pregnancy and
birth cohort in Canada.
2. Materials and methods
2.1. Study participants
We used data from the Maternal-Infant Research on Environmental
Chemicals (MIREC) study, a prospective pregnancy and birth cohort of
2000 pregnant women from ten cities (11 study sites) across Canada.
Details about eligibility, recruitment, and follow-up are previously de-
scribed (Arbuckle et al., 2013). Briefly, we recruited pregnant women
during the first trimester of pregnancy from obstetric and prenatal
clinics between 2008 and 2011. Women must have planned on deli-
vering at a local hospital, been able to communicate in English or
French, been ≥18 years of age, and agreed to participate in the cord
blood collection component of the MIREC study. We excluded women if
they had a history of major chronic disease, illicit drug use, threatened
abortion, or were carrying a fetus with a known malformation or ab-
normality. Among 8716 women we approached to participate in
MIREC, 5108 (58.6%) were eligible, 1983 (38.8%) consented and
participated, and 1861 had singleton lives births.
The ethics review boards or committees from Québec and Sainte-
Justine research centers, Health Canada, and participating recruitment
sites approved this research. We provided potential participants with
information about the student design and objectives before asking them
to sign informed consent forms for the prenatal and child follow-up part
of the study.
2.2. Prenatal triclosan exposure assessment
At an average of 12.1 weeks gestation (range: 5.1–15.0) we col-
lected a single urine sample from women. Samples were aliquoted and
frozen at−20 °C within 2 h of collection, and later shipped on dry ice to
the MIREC coordinating center in Montréal where they were stored at
−30 °C. For triclosan analysis, urine samples were shipped to the
Centre de toxicologie du Québec, Institut National de Santé Publique du
Québec. We quantified total (conjugated+ free) triclosan concentra-
tions using gas chromatography coupled with tandem mass spectro-
metry (GC–MS/MS) (Arbuckle et al., 2015b). Field blanks were used to
assess for potential exogenous contamination from the materials used
for urine specimen collection and storage, and from the environment of
the collection sites. All field blanks were free of triclosan contamina-
tion. Several quality control samples, reagents blanks, and urine blanks
were incorporated into each batch of samples (Arbuckle et al., 2015b).
The intraday precision ranged from 2.5% to 7.7%, and the interday
precision ranged from 4.3% to 13%.
We measured urine specific gravity (SG) with a refractometer and
used SG to account for individual variation in urine dilution by SG-
standardizing urinary triclosan concentrations with the following for-













where Ps is the SG-standardized triclosan concentration, Pi is the ob-
served triclosan concentration for the i-th woman, SGm is the median
SG (1.013), and SGi is the observed SG for the i-th woman. We log10-
transformed SG-standardized urinary triclosan concentrations to reduce
the influence of extreme observations.
2.3. Child follow-up and neurobehavior assessments
We conducted follow-up on 896 (46.9%) singleton children from all
MIREC study sites when they were approximately 3 years old (mean:
3.4 years; range: 2.8–4.2). Among these, 794 had urinary triclosan
concentrations measured at about 12 weeks, complete covariate data,
and internet questionnaire-based assessments of neurobehavior
(Supplemental Table 1; Supplemental Fig. 1). We conducted additional
in-person neurobehavioral assessments of 531 (27.8%) children with
complete data from the 7 most populous MIREC study sites
(Supplemental Table 1; Supplemental Fig. 1). At this visit, trained re-
search personnel measured child anthropometry, collected children's
blood and urine, and administered questionnaires to the parents and
neurobehavioral assessments to the child. Minor variations in the
sample size arose from invalid administration of in-person tests (e.g.,
inadequate test environment) or incomplete questionnaires (e.g., parent
did not complete surveys). Because of limited resources, we were un-
able to conduct follow-up on all MIREC study participants and only
conducted follow-up on children who were in our target age range
(~3–4 years) during the follow-up phase of this study. Thus, our follow-
up rates reflect this, as well as loss to follow-up.
We assessed child neurobehavior with standardized and age-ap-
propriate tests described below because previous studies report that the
traits they measure are associated with prenatal environmental che-
mical exposures, including chemicals that may disrupt thyroid function
(Dietrich et al., 2005; Chen et al., 2014; Vuong et al., 2015). These tests
are routinely used in studies of developmental neurotoxicants (Dietrich
et al., 2005). Additionally, performance on or behaviors measured by
some of these tests have been associated with alterations in maternal
thyroid function during pregnancy (Ghassabian et al., 2011; Korevaar
et al., 2015). Finally, these tests provide a broad assessment of child
neurobehavior, including omnibus features like child cognitive abilities
(i.e., IQ), as well as specific features of clinical disorders like attention-
deficit/hyperactivity disorder (ADHD) (e.g., externalizing behaviors)
and autism spectrum disorder (ASD) (e.g., affect recognition).
Caregivers completed the Behavioral Assessment System for
Children-2 (BASC-2) and two subscales from the Behavior Rating
Inventory of Executive Function-Preschool (BRIEF-P) using paper-and
pencil versions or an internet-based platform. The BASC-2 is a reliable
and valid 134-item assessment of children's problem behaviors in home
and community settings (Reynolds and Kamphaus, 2002). The BASC-2
include three composite scores that measure children's total (Behavioral
Symptom Index [BSI]), internalizing, and externalizing behavior pro-
blems, as well as eight clinical subscales (attention, atypicality, ag-
gression, anxiety, depression, hyperactivity, somatization, and with-
drawal). Children's executive function were assessed by caregiver
report using 27 items from the working memory and plan/organize
subscales of the BRIEF-P (Gioia et al., 2003).
During the in-person assessment, children who were between the
ages of 36 and 47months completed the Receptive Vocabulary,
Information, Block Design, Object Assembly, and Picture Naming
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subtests of the Wechsler Preschool and Primary Scale of Intelligence-III
(WPPSI-III) and all children completed the Affect Recognition subtest of
the A Developmental Neuropsychological Assessment-II (NEPSY-II).
The WPSSI-III is a reliable and valid assessment of children's cognitive
abilities (Wechsler, 2002). In the Affect Recognition test, children are
asked to identify emotions from photographs of children's faces and
scores on this test reflect visual attention, visual discrimination, and
facial recognition (Korkman et al., 2007).
Caregivers completed the Social Responsiveness Scale-2 (SRS-2)
during the in-person assessment. The SRS-2 is a valid and reliable 65-
item assessment that assesses communication, interpersonal behaviors,
and repetitive or stereotypic behaviors. It provides a summary scale,
five subscales (social cognition, social communication, social aware-
ness, social motivation, and restricted interests and repetitive beha-
viors), and two scales related to the Diagnostic and Statistical Manual-V
diagnostic criteria for autism spectrum disorders (Bolte et al., 2008).
Study staff from each participating study site completed a 3-day
training session that was led by a PhD-level psychologist (E.O.) and
focused on specialized training of these assessment tools. The training
emphasized the importance of providing an ideal and standardized
environment in the home by ensuring that the test area was well-lit,
quiet, and free from distractions and interruptions. A single staff person
from each study site administered in-person assessments. At the time of
child assessment, both study staff and caregivers were blinded to mo-
ther's triclosan concentrations during pregnancy.
Using software provided by test publishers and United States po-
pulation-based normative data, we calculated full-scale IQ (FSIQ),
performance IQ (PIQ), and verbal IQ (VIQ) scores, as well as subtest
scores for the WPPSII-III. Higher WPPSII-III scores indicate better per-
formance. The same methods were used to calculate T-scores for the
BASC-2, BRIEF-P, and SRS-2. For BASC-2, BRIEF-P, and SRS-2 higher T-
scores indicate poorer functioning and more of those behaviors. Finally,
we calculated scaled Affect Recognition test scores, where higher scores
indicate better recognition of facial expressions, visual attention, and
visual discrimination.
2.4. Covariates
Trained research assistants administered standardized interviews
during the 1st and 3rd trimesters to assess potential confounders. These
included maternal race, education, age at delivery, household income,
employment, parity, and self-reported alcohol consumption and
smoking during pregnancy. Additionally, caregivers completed stan-
dardized questionnaires at the time of child assessment that measured
maternal depressive symptoms (Center for Epidemiological Studies-
Depression Scale 10), parenting stress (Parenting Relationship
Questionnaire), the duration of breastfeeding, caregiver-reported de-
linquent behavior during adulthood, and whether the child received
any regularly scheduled daycare. Finally, during in-person visits, the
HOME Inventory was administered, a semi-structured interview that
measures the quality and quantity of the caregiving environment
(Bradley et al., 1988).
We used directed acyclic graphs (DAGs) to identify variables that
were potential causes of both urinary triclosan concentrations and at
least one neurobehavioral outcome (Stacy et al., 2017), but not vari-
ables that were colliders or causal intermediates (Supplemental Fig. 2).
All analyses were adjusted for maternal race, education, age, household
income, employment, marital status, parity, smoking during pregnancy,
alcohol use during pregnancy, parental stress, maternal depressive
symptoms, and months of exclusive breastfeeding.
2.5. Statistical methods
First, we described the central tendency of urinary triclosan con-
centrations and children's BSI, FSIQ, and SRS-2 total scores by covari-
ates. Then, using natural splines, we tested for non-linear relations
between urinary triclosan concentrations and neurobehavioral scores.
Using multivariable linear regression, we estimated the unadjusted and
covariate-adjusted associations between log10-transformed SG-standar-
dized urinary triclosan concentrations and neurobehavioral test scores.
To further characterize dose-response relations, we estimated the ad-
justed mean of summary scale scores from BASC-3 and WPPSI-III, SRS-2
total, and NEPSY: Affect recognition in relation to quintiles of urinary
triclosan concentrations. We estimated sex-specific associations among
boys and girls using product interaction terms between child sex and
urinary triclosan concentration variables. We considered modification
to be present when the triclosan× child sex p-value was ≤0.10.
To examine the impact of adjusting for study site, we compared
models that did not adjust for study site, included study site as a cov-
ariate, or used generalized estimating equations (GEEs) to account for
study site. Adjusting for study site did not meaningful change our re-
sults and we ultimately decided to not adjust for study site.
2.6. Sensitivity analysis
To evaluate the robustness of our results, we conducted several
sensitivity analyses. First, prior studies have shown that folic acid
supplementation during early pregnancy may have beneficial effects on
neurodevelopment beyond its effect on neural tube defect prevention,
including mitigating the effect of some neurotoxicant exposures (Gao
et al., 2016; Schmidt et al., 2017). Among women with reported sup-
plement use during the first trimester of pregnancy, we examined
whether taking any vs. no folic acid supplements modified the asso-
ciation between prenatal urinary triclosan concentrations and neuro-
behavioral outcomes by including a product interaction term between
triclosan concentration× folic acid supplementation. Second, we
compared the results from models that did and did not adjust for cov-
ariates that were measured at the child-follow up visit because cov-
ariates at the child follow-up visit occurred after exposure and may not
be associated with prenatal urinary triclosan concentrations. Third, we
adjusted for maternal receipt of welfare support (n=17). Fourth,
among children who completed the in-person visit, we adjusted for
daycare attendance and HOME Inventory. We compared results from
models adjusted for primary covariates and primary covariates plus
daycare attendance and HOME inventory scores among the subset of
children who completed the in-person follow-up to avoid potential se-
lection biases that result from not completing the in-person follow-up.
Fifth, because there can be additional age-related variation in behavior
and cognition that is not captured by the test developer's standardiza-
tion, we also adjusted for child age. Finally, we examined if our method
of measuring urine dilution influenced our results by comparing models
that used creatinine-standardized urinary triclosan concentrations to
those that used SG-standardized triclosan concentrations.
3. Results
Women in the MIREC study generally were white
(86%),> 25–35 years of age (61%), married or living with a partner
(98%), employed (89%), university educated (69%), of higher income
(> $100 K, 41%), non-smokers during pregnancy (96%), and non-
consumers of alcohol during pregnancy (55%) (Table 1).
The median urinary triclosan concentration during pregnancy was
8.8 ng/mL (range:< LOD-2621 ng/mL), with 0.4% of samples having
concentrations below the LOD. We observed a bimodal distribution of
log10-transformed SG-standardized urinary triclosan concentrations
where the median within each mode was approximately 6.5 and
300 ng/mL (Supplemental Fig. 3). Median urinary triclosan con-
centrations were higher among pregnant women who were> 25–35
years of age, white, had a graduate degree, not married or living alone,
employed, had a household income greater than $100,000 (CAD), and
had 2 or more children (Table 1). Median SG-standardized urinary
triclosan concentrations during pregnancy were 8.9 ng/mL, 8.8 ng/mL,
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and 9.1 ng/mL among women whose children were not followed up
(893), followed up in-person or via internet (794), and followed in-
person (531), respectively.
The mean BSI, FSIQ, and SRS-2 total scores were 51 (SD:7), 107
(SD:14), and 45 (SD:6), respectively (Table 1). Males had lower mean
FSIQ scores, and higher mean BSI and SRS-2 scores compared to fe-
males. On average, children born to women who were>35 years of
age, had a graduate degree, were married or living with a partner,
employed, and had a household income greater than $100,000 (CAD)
had lower BSI and SRS-2 scores and higher FSIQ scores (Table 1).
Associations between prenatal urinary triclosan concentrations and
neurobehavioral outcomes were similar before and after adjustment for
potential confounders (Table 2). Triclosan was not associated with
scores on the BRIEF-P, WPPSI-III summary scales, SRS-2, or NEPSY
affect recognition. However, triclosan was associated with less ex-
ternalizing behaviors; for every 10-fold increase in triclosan, there was
a 0.5 point (95% CI: −1.1, 0.0) decrease in scores. Triclosan was as-
sociated with better scores on some subscales of the BASC-2 and subt-
ests of the WPPSI-III; for every 10-fold increase in triclosan, there was a
0.6 point (95% CI: −1.2, −0.1) decrease in hyperactivity behavior
scores and a 0.2 point (95% CI: 0.0, 0.5) increase in picture completion
scores (Table 2).
We did not observe evidence of non-linear relations between tri-
closan and child neurobehavior. All non-linearity p-values in models
containing spline terms were ≥0.1, except for the relationship between
triclosan and somatization (p-value= 0.01). However, the 95% CI was
Table 1
Central tendency and variation of specific gravity standardized maternal urinary triclosan concentrations during pregnancy and child BASC-2 BSI, SRS-2 total, and WPPSI-III FSIQ scores
at three years of age according to covariates: the MIREC study.
Variable Triclosan (ng/mL) BSI SRS-2 FSIQ
N % Median (25th,75th) N % Mean (SD) N % Mean (SD) N Mean (SD)
Overall 794 – 8.8 (2.5, 107) 790 – 51 (7) 524 – 45 (6) 528 – 107 (14)
Maternal age
18–25 years 25 3.1 6.4 (2.5, 67) 25 3.2 50 (5) 14 2.7 48 (7) 15 2.8 103 (12)
>25–35 years 486 61.2 9.1 (2.6, 105) 483 61.1 51 (7) 332 63.4 46 (6) 333 63.1 107 (14)
>35 years 283 35.6 8.3 (2.3, 113) 282 35.7 50 (7) 178 34.0 45 (6) 180 34.1 108 (14)
Maternal race
White 687 86.5 9.4 (2.5, 117) 685 86.7 51 (7) 452 86.3 45 (6) 452 85.6 108 (13)
Asian/Pacific Islander 26 3.3 8.7 (1.9, 73) 26 3.3 52 (6) 14 2.7 46 (5) 15 2.8 110 (11)
Other 47 5.9 4.5 (1.8, 54) 45 5.7 51 (8) 34 6.5 48 (6) 37 7.0 97 (15)
Multi-racial 34 4.3 6.8 (2.6, 19) 34 4.3 50 (6) 24 4.6 46 (6) 24 4.5 107 (15)
Maternal education
Graduate degree 226 28.5 12 (2.5, 176) 226 28.6 50 (6) 144 27.5 44 (5) 145 27.5 110 (12)
University degree 318 40.1 9.2 (2.5, 86) 317 40.1 51 (7) 215 41.0 45 (7) 216 40.9 108 (14)
Some college, trade school, or diploma 208 26.2 6.6 (2.2, 86) 205 25.9 51 (7) 142 27.1 46 (6) 143 27.1 103 (14)
High school or less 42 5.3 9.9 (2.7, 119) 42 5.3 51 (8) 23 4.4 47 (7) 24 4.5 99 (11)
Marital status
Married or living with partner 774 97.5 8.8 (2.5, 108) 771 97.6 51 (7) 508 96.9 45 (6) 512 97.0 107 (14)
Not married or living alone 20 2.5 9.5 (2.9, 79) 19 2.4 54 (9) 16 3.1 50 (7) 16 3.0 102 (15)
Household income (CAD)
>$100 K 322 40.6 13 (3.1, 165) 321 40.6 50 (7) 209 39.9 44 (6) 211 40.0 109 (13)
$80 K–100 K 266 33.5 6.5 (1.9, 58) 265 33.5 51 (7) 171 32.6 45 (6) 172 32.6 107 (14)
$40 K–<80 K 132 16.6 6.7 (2.2, 48) 130 16.5 51 (6) 90 17.2 46 (7) 91 17.2 104 (14)
<$40 K 74 9.3 11 (2.5, 64) 74 9.4 53 (8) 54 10.3 48 (6) 54 10.2 104 (14)
Employment
No 91 11.5 6.6 (2.2, 28) 91 11.5 52 (8) 59 11.3 47 (9) 59 11.2 102 (17)
Yes 703 88.5 9.2 (2.5, 114) 699 88.5 50 (7) 465 88.7 45 (6) 469 88.8 108 (13)
Parity
0 351 44.2 9.1 (2.7, 119) 349 44.2 51 (7) 231 44.1 46 (6) 234 44.3 109 (14)
1 326 41.1 8.3 (2.2, 94) 324 41.0 51 (7) 214 40.8 45 (6) 214 40.5 106 (14)
2+ 117 14.7 9.2 (2.8, 93) 117 14.8 50 (6) 79 15.1 45 (7) 80 15.2 104 (12)
Smoking during pregnancy
No 765 96.3 8.8 (2.5, 100) 761 96.3 51 (7) 508 96.9 45 (6) 512 97.0 107 (14)
Yes 29 3.7 6.7 (1.7, 140) 29 3.7 51 (9) 16 3.1 49 (7) 16 3.0 98 (16)
Alcohol use during pregnancy
No 439 55.3 8.1 (2.5, 85) 436 55.2 51 (6) 299 57.1 45 (6) 302 57.2 106 (14)
Yes 355 44.7 9.2 (2.4, 117) 354 44.8 50 (7) 225 42.9 45 (6) 226 42.8 108 (13)
Duration of exclusive breastfeeding
≥6months 405 51.0 9.6 (2.6, 111) 404 51.1 51 (6) 260 49.6 45 (6) 262 49.6 109 (13)
<6months 389 49.0 8 (2.3, 99) 386 48.9 51 (7) 264 50.4 46 (7) 266 50.4 105 (14)
Parenting stressa
< 1 SD 667 84.0 9 (2.5, 108) 666 84.3 49 (6) 438 83.6 44 (5) 440 83.3 108 (13)
≥1 SD 127 16.0 8 (2.0, 85) 124 15.7 57 (7) 86 16.4 52 (8) 88 16.7 102 (17)
Maternal CES-D score
<16 768 96.7 8.8 (2.5, 105) 765 96.8 50 (7) 505 96.4 45 (6) 509 96.4 107 (14)
≥16 26 3.3 8.3 (2.0, 211) 25 3.2 54 (7) 19 3.6 48 (5) 19 3.6 107 (12)
Child sex
Male 389 49.0 7.6 (2.0, 73) 387 49.0 51 (7) 254 48.5 46 (7) 258 48.9 104 (15)
Female 405 51.0 9.5 (2.7, 125) 403 51.0 50 (6) 270 51.5 44 (5) 270 51.1 109 (12)
Folic acid supplement during pregnancy
No 80 10.7 8.8 (2.1, 95) 80 10.8 51 (6) 353 67.4 46 (7) 50 10.2 106 (12)
Yes 666 89.3 9.8 (2.6, 108) 662 89.2 51 (8) 171 32.6 45 (6) 439 89.8 107 (14)
BSI: Behavior Symptom Index of the Behavioral Assessment System for Children-2; CES-D: Center for Epidemiologic Studies Depression Scale; FSIQ: Full Scale IQ of the Wechsler
Preschool and Primary Scales of Intelligence; and SRS-2: Total T-Score from the Social Responsiveness Scale.
a This indicates that parenting stress was less than or ≥1 standard deviation above the mean.
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wide at the tails of the triclosan concentration distribution. When ex-
amining quintiles of prenatal urinary triclosan concentrations we did
not observe evidence of monotonic dose-response relationships for the
notable associations mentioned above (Figs. 1, 2, and 3; Supplemental
Table 2). Children born to women in the 2nd, 3rd, 4th, and 5th quintiles
of prenatal urinary triclosan concentrations had BASC-2 externalizing
scores that were 1.7 (95% CI: −3.0, −0.1), 1.6 (95% CI: −3.0, 0.0),
1.9 (95% CI: −4.0, −0.3), and 2.0 (95% CI: −4.0, −0.4) points lower,
respectively, than children born to women in the first quintile (Fig. 1,
Supplemental Table 2). No monotonic dose-response relationships were
found between prenatal triclosan concentrations and subtest scores on
any of the other instruments (results not shown).
Generally, child sex did not modify the association between prenatal
triclosan concentrations and most neurobehavioral scores. However,
child sex modified the association between triclosan and two BASC-2
clinical subscales (triclosan× child sex p-values= 0.10). A 10-fold
increase in triclosan was associated with a 1.0 point (95% CI: −1.9,
−0.2) decrease in somatization scores among girls, but not among boys
(β: 0; 95% CI: −0.9, 0.9). A 10-fold increase in triclosan was associated
with a 0.9 point (95% CI: −1.7, 0.0) decrease in depression scores
among boys, but not girls (β: 0.1; 95% CI: −0.7, 1.0) (Table 2).
3.1. Sensitivity analyses
Folic acid supplement use during pregnancy modified some asso-
ciations between prenatal urinary triclosan concentrations and neuro-
behavior at three years of age (triclosan× folic acid supplementation p-
value≤ 0.1); however, only a small number (n=51) of women did not
take folic acid containing supplements during pregnancy, the estimates
were imprecise, and the pattern of associations did not consistently
show that triclosan was associated with worse neurobehavior among
children from women who did not take folic acid supplements
(Supplemental Table 3). Adjusting for covariates collected at age
3 years, welfare receipt, child age, or using creatinine-standardized
prenatal urinary triclosan concentrations did not appreciably change
the results of our analyses (Supplemental Table 4). Among the subset of
children who completed the in-person follow-up, adjusting for HOME
Inventory scores and daycare use did not appreciably change our results
(Supplemental Table 4).
4. Discussion
Prenatal urinary triclosan concentrations during pregnancy were
not associated with most neurobehavioral outcomes among 3-year old
Table 2
Adjusted difference in behavioral and cognitive test score at three years of age with 10-fold increase in specific gravity standardized maternal urinary TCS concentrations during
pregnancy: the MIREC studya,b.
Neurodevelopmental test N All children (unadjusted) All children (adjusted) Boys Girls TCS× sex p-value
β 95% CI β 95% CI β 95% CI β 95% CI
BASC-2 summary scales
BSI 790 −0.3 −0.8, 0.2 −0.3 −0.7, 0.2 −0.5 −1.1, 0.2 −0.1 −0.7, 0.5 0.41
Externalizing 790 −0.6 −1.2, 0.0 −0.5 −1.1, 0.0 −0.7 −1.5, 0.0 −0.1 −0.9, 0.6 0.27
Internalizing 788 −0.3 −0.9, 0.4 −0.2 −0.9, 0.4 −0.3 −1.2, 0.6 −0.3 −1.1, 0.6 0.97
BASC-2 clinical scales
Hyperactivity 791 −0.7 −1.3, −0.1 −0.6 −1.2, −0.1 −0.7 −1.5, 0.1 −0.5 −1.2, 0.3 0.67
Aggression 790 −0.4 −1.1, 0.2 −0.3 −0.9, 0.3 −0.7 −1.5, 0.2 0.2 −0.7, 1.0 0.16
Anxiety 785 0.3 −0.4, 1.0 0.2 −0.5, 0.9 0.2 −0.9, 1.2 0.1 −0.9, 1.1 0.94
Depression 790 −0.3 −1.0, 0.3 −0.3 −0.9, 0.3 −0.9 −1.7, 0.0 0.1 −0.7, 1.0 0.10
Somatization 790 −0.6 −1.2, 0.0 −0.5 −1.1, 0.1 0.0 −0.9, 0.9 −1.0 −1.9, −0.2 0.10
Atypicality 791 0.0 −0.6, 0.6 0.0 −0.5, 0.6 0.3 −0.5, 1.1 −0.2 −1.0, 0.5 0.35
Withdrawal 788 0.0 −0.7, 0.6 −0.1 −0.8, 0.5 −0.3 −1.3, 0.6 0.0 −0.9, 0.9 0.60
Attention 794 0.1 −0.2, 0.3 0.1 −0.2, 0.3 0.3 −0.1, 0.6 −0.1 −0.5, 0.2 0.16
BRIEF-P
Working memory 792 −0.5 −1.3, 0.2 −0.3 −1.0, 0.4 −0.2 −1.3, 0.8 −0.5 −1.5, 0.5 0.71
Plan/organize 794 −0.6 −1.3, 0.2 −0.4 −1.1, 0.3 −0.6 −1.6, 0.4 −0.4 −1.4, 0.6 0.79
WPPSI-III summary scales
FSIQ 528 0.3 −1.0, 1.5 −0.1 −1.2, 1.1 −0.5 −2.1, 1.2 0.2 −1.4, 1.8 0.59
VIQ 526 0.9 −0.3, 2.1 0.6 −0.5, 1.8 0.4 −1.2, 2.0 0.6 −0.9, 2.2 0.88
PIQ 523 −0.5 −1.8, 0.9 −0.8 −2.1, 0.6 −1.2 −3.1, 0.7 −0.5 −2.3, 1.4 0.58
WPPSI-III subtests
Vocabulary 529 0.1 −0.1, 0.4 0.1 −0.1, 0.4 0.1 −0.3, 0.4 0.1 −0.2, 0.5 0.78
Block design 526 0.0 −0.3, 0.2 −0.1 −0.3, 0.2 −0.1 −0.5, 0.2 0.0 −0.4, 0.3 0.69
Information 518 0.2 −0.1, 0.4 0.1 −0.1, 0.3 0.1 −0.2, 0.4 0.1 −0.2, 0.4 0.90
Object design 526 −0.1 −0.4, 0.2 −0.2 −0.4, 0.1 −0.2 −0.6, 0.1 −0.1 −0.5, 0.2 0.64
Picture completion 527 0.3 0.0, 0.6 0.2 0.0, 0.5 0.4 0.0, 0.7 0.1 −0.3, 0.4 0.23
SRS-2
Total 524 −0.1 −0.7, 0.4 −0.2 −0.7, 0.3 −0.1 −0.8, 0.6 −0.2 −0.8, 0.4 0.83
Awareness 524 −0.2 −1.0, 0.5 −0.2 −0.9, 0.4 −0.4 −1.3, 0.6 0.0 −0.9, 0.9 0.58
Cognition 524 0.2 −0.4, 0.8 0.1 −0.4, 0.6 0.1 −0.6, 0.8 0.1 −0.5, 0.8 0.95
Communication 524 −0.4 −0.9, 0.2 −0.4 −0.9, 0.1 −0.2 −0.9, 0.5 −0.5 −1.2, 0.1 0.48
Motivation 524 0.0 −0.7, 0.7 −0.1 −0.7, 0.5 −0.1 −1.0, 0.8 −0.2 −1.0, 0.6 0.89
Restricted 524 0.0 −0.7, 0.6 −0.1 −0.6, 0.5 0.0 −0.7, 0.8 −0.1 −0.8, 0.7 0.85
DSM Social 524 −0.1 −0.7, 0.4 −0.2 −0.7, 0.3 −0.1 −0.8, 0.6 −0.2 −0.9, 0.4 0.75
DSM Restricted 524 0.0 −0.7, 0.6 −0.1 −0.6, 0.5 0.0 −0.7, 0.8 −0.1 −0.8, 0.7 0.85
NEPSY: affect recognition 485 0.1 −0.2, 0.3 0.0 −0.2, 0.2 0.0 −0.3, 0.3 0.0 −0.3, 0.3 0.87
BASC-2: Behavioral Assessment System for Children-2; BSI: Behavior Symptom Index of the BASC-2; WPPSI: Wechsler Preschool and Primary Scales of Intelligence-III; FSIQ: Full Scale IQ;
VIQ: Verbal IQ; PIQ: Performance IQ; NEPSY: A Developmental Neuropsychological Assessment; and SRS-2: Social Responsiveness Scale.
a Adjusted for maternal race, education, age, marital status, employment, household income, smoking during pregnancy, alcohol use during pregnancy, parity, months of exclusive
breastfeeding, parental stress, and maternal depressive symptoms.
b Positive coefficients for the BASC-2, BRIEF-P, and SRS-2 indicate that TCS concentrations are associated with more behavior problems. Positive coefficients for the WPPSI-III and
NEPSY indicate that TCS is associated with better performance.
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Fig. 1. Covariate adjusted child mean BASC-2 summary
scale test scores by maternal urinary triclosan quintile: the
MIREC study.
Adjusted for maternal race, education, age, marital status,
employment, household income, smoking during preg-
nancy, alcohol use during pregnancy, parity, months of
exclusive breastfeeding, parental stress, and maternal de-
pressive symptoms. Maternal urinary triclosan concentra-
tions are specific gravity standardized. Quintile ranges were
0.17–<1.9, 1.9–<5.4, 5.4–<19, 19–<179, and
179–2745 ng/mL. Error bars are the 95% confidence in-
tervals. N's are 790, 790, 788 for BSI, Externalizing, and
Internalizing, respectively. Note that the y-axis scale
changes in each row.
Fig. 2. Covariate adjusted child mean WPPSI-III summary
scale test scores by maternal urinary triclosan quintile: the
MIREC study.
Adjusted for maternal race, education, age, marital status,
employment, household income, smoking during preg-
nancy, alcohol use during pregnancy, parity, months of
exclusive breastfeeding, parental stress, and maternal de-
pressive symptoms. Maternal urinary triclosan concentra-
tions are specific gravity standardized. Quintile ranges were
0.17–<1.9, 1.9–<5.4, 5.4–<19, 19–<179, and
179–2745 ng/mL. Error bars are the 95% confidence in-
tervals. ‡-N's are 528, 526, and 523 for PSIQ, VIQ, and PIQ,
respectively. Note that the y-axis scale changes in each row.
Fig. 3. Covariate adjusted mean child SRS-2 Total and
NEPSY test scores by maternal urinary triclosan quintile:
the MIREC study.
Adjusted for maternal race, education, age, marital status,
employment, household income, smoking during preg-
nancy, alcohol use during pregnancy, parity, household
income, months of exclusive breastfeeding, parental stress,
and maternal depressive symptoms. Maternal urinary tri-
closan concentrations are specific gravity standardized.
Quintile ranges were 0.17–<2.0, 2.0–<5.8, 5. 8–<21,
21–<189, and 189–2745 ng/mL. Error bars are the 95%
confidence intervals. N's are 524 for SRS-2 Total and 485
NEPSY. Note that the y-axis scale changes in each row.
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children in this cohort. However, higher urinary triclosan concentra-
tions during pregnancy were weakly associated with better parent-re-
ported externalizing and hyperactivity scores, and picture completion
scores. In general, the relationships between prenatal urinary triclosan
concentrations and most neurobehavioral outcomes were not modified
by child sex. A strength of this study is the large sample size, which
allowed us to precisely estimate the presence of associations among all
children, and boys and girls separately.
We are aware of only one epidemiological study examining the as-
sociation between prenatal triclosan exposure and neurodevelopment.
Braun et al. found that prenatal urinary triclosan concentrations were
not associated with visual-spatial abilities among 8-year-old children,
nor were associations modified by child sex (Braun et al., 2017b). This
study had two urine samples collected at 16 and 26weeks of pregnancy
and median prenatal urinary triclosan concentrations were slightly
higher than median concentrations in this study (18 vs. 13 μg/g Cr).
Previous in vitro research has shown that triclosan exposure can
induce apoptosis in neocortical neurons by activating and stimulating
apoptotic signaling pathways and inducing the aryl hydrocarbon re-
ceptor (AhR)-dependent apoptosis through impairment of Cyp1a1 sig-
naling and transcriptional activity of AhR (Szychowski et al., 2015;
Szychowski et al., 2016). Prenatal triclosan exposure may also affect
neurodevelopment by reducing levels of thyroid hormones during
pregnancy as suggested by multiple animal studies (Paul et al., 2012;
Paul et al., 2010) and a two studies of pregnant women and their infants
(Wang et al., 2017; Braun et al., 2017a). Given the potential for tri-
closan to disrupt thyroid hormone homeostasis in pregnant women and
the neonate, future epidemiological studies could examine thyroid
hormone levels as an outcome and determine if thyroid hormones
mediate any associations between prenatal triclosan exposure and child
neurobehavior.
Our null findings could be attributed to triclosan exposure mis-
classification. Triclosan has a short half-life (< 24 h) and exposures are
episodic in nature. Thus, having one urine sample during the first tri-
mester of pregnancy could have resulted in exposure misclassification.
Given that urinary triclosan concentrations have good reproducibility
over the course of a day (intraclass correlation coefficient (ICC) of
0.77–0.79) (Perrier et al., 2016) and moderate over the pregnancy
(Perrier et al., 2016; Schug et al., 2015), it is possible our results are
attenuated towards the null, assuming non-differential exposure mis-
classification. Furthermore, in a cohort of pregnant Canadian women
similar to MIREC, a single spot urine sample collected at any time
during or post-pregnancy was able to predict a participant's geometric
mean urinary TCS level corresponding to low, medium, or high ex-
posure with 86.7% accuracy (Perrier et al., 2016). The extent of the
misclassification would depend on the duration of the critical window
of exposure. A simulation study found that under certain assumptions,
associations between health outcomes and urinary biomarker con-
centrations with intraclass correlation coefficients of ~0.6 can be at-
tenuated towards the null by 40, 25, and 18% when one, two, or three
urine samples, respectively are pooled prior to laboratory analysis
(Perrier et al., 2016). Future studies could use measurement error
correction methods described by Perrier and others to “dis-attenuate”
associations between non-persistent chemical biomarkers and health
outcomes.
In addition, the timing of our exposure assessment may have led to
null results if the critical window of exposure was later in gestation or
in the post-natal period. Due to funding limitations we were only able
to quantify triclosan concentrations in one urine sample during the first
trimester of pregnancy. Other neurodevelopmental processes that occur
later in gestation or during childhood (e.g., myelination) may be more
sensitive to triclosan exposure (Schug et al., 2015), but we were unable
to examine those associations. Finally, we may have missed an asso-
ciation between prenatal triclosan exposure and neurobehavior if the
effects do not manifest until later in life or if they are traits that develop
later in childhood (e.g., executive function and anxiety). Some prior
studies examining other toxicant-associated alterations in child neuro-
behavior have observed that these associations may not manifest until
later in childhood (Chen et al., 2014; Braun et al., 2017c).
A strength of this study is that we comprehensively assessed nu-
merous features of children's behaviors and cognitive abilities at three
years of age. Moreover, both interviewers and parents were blinded to
the mother's triclosan concentrations.
There are some limitations of this study that should be acknowl-
edged. First, not all children completed the follow-up portions of the
study due to budgetary and logistic constraints, and there was loss to
follow-up of some participants. Mothers of children that did not com-
plete the follow-up were more likely to be younger, non-White, less
educated, and have lower household income than mothers of children
who did not complete follow-up. While those lost to follow-up may also
be more likely to have adverse neurodevelopment, prenatal triclosan
concentrations at baseline did not differ among those with and without
follow-up. Second, while we adjusted for many potential confounders,
which did not appreciably change our results, there is the possibility of
residual confounding from other factors associated with both triclosan
exposure and child neurobehavior. For instance, women with higher
education had higher urinary triclosan concentrations and their chil-
dren had better behavioral and cognitive ability scores, which could
produce negative confounding (biased towards the null). While we
observed negative confounding in a prior study examining the asso-
ciation between prenatal triclosan exposure and neonatal outcomes
(Etzel et al., 2017), we did not find evidence of it in this study. The
absence of appreciable confounding from sociodemographic factors in
these data may be due to less variation in these factors among MIREC
women. While the MIREC cohort is relatively homogenous with regards
to sociodemographic features, and this is advantageous with regards to
potential confounding, it may limit the generalizability of these results.
Finally, we did not measure maternal IQ. While maternal education is a
reasonable proxy of IQ, having a measurement of maternal IQ may also
be important to explain additional variation in child IQ not explained
by maternal education.
5. Conclusions
We found few notable associations between a single measurement of
prenatal urinary triclosan concentrations and multiple features of child
behavior and cognitive abilities at three years of age in the MIREC
cohort. Given the potential for environmental exposures to impact
neurodevelopment and potential limitations of this study including the
use of only a single triclosan measurement during early pregnancy,
future studies should test these associations using repeated measures of
triclosan exposure during pregnancy and childhood to determine if
there are particular periods of heightened vulnerability to triclosan
exposure.
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